Strategic partnership Willowglade Technologies recently partnered with Flatiron Health, signaling validation of its Unified Digital Patient Experience Platform within oncology care workflows and opening potential co-sell opportunities with Flatiron’s network of health systems and practice sites.

Oncology focus The company targets community oncology practices with a platform designed to streamline communication, care coordination, and patient engagement, presenting a clear entry point for expanding within outpatient cancer care providers seeking digital transformation.

FDA alignment An extension to the Personalized Patient Experience Platform addresses FDA eConsent and patient education requirements, suggesting a potential upsell to clients needing compliant, enrollment and education workflow enhancements.

Growth readiness With a lean team and revenue in the low millions, Willowglade presents a scalable partner profile for managed services or co-development deals, where a larger systems integrator could extend reach while leveraging Willowglade’s oncology-focused platform.

Data-driven care The platform’s emphasis on data-driven, personalized patient support indicates opportunities to cross-sell advanced analytics, care coordination modules, and integration with health information exchanges to improve outcomes and operational efficiency.